- Home
- FNWB vs GNLX Comparison
FNWB vs GNLX Comparison
Compare FNWB & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- GNLX
- Stock Information
- Founded
- FNWB 1923
- GNLX 2001
- Country
- FNWB United States
- GNLX United States
- Employees
- FNWB N/A
- GNLX N/A
- Industry
- FNWB Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- GNLX Health Care
- Exchange
- FNWB Nasdaq
- GNLX Nasdaq
- Market Cap
- FNWB 95.3M
- GNLX 103.6M
- IPO Year
- FNWB 2015
- GNLX 2023
- Fundamental
- Price
- FNWB $11.07
- GNLX $2.46
- Analyst Decision
- FNWB Hold
- GNLX Strong Buy
- Analyst Count
- FNWB 1
- GNLX 4
- Target Price
- FNWB $11.00
- GNLX $18.25
- AVG Volume (30 Days)
- FNWB 23.8K
- GNLX 177.9K
- Earning Date
- FNWB 10-29-2024
- GNLX 11-14-2024
- Dividend Yield
- FNWB 2.57%
- GNLX N/A
- EPS Growth
- FNWB N/A
- GNLX N/A
- EPS
- FNWB N/A
- GNLX N/A
- Revenue
- FNWB $50,768,000.00
- GNLX $8,000.00
- Revenue This Year
- FNWB N/A
- GNLX N/A
- Revenue Next Year
- FNWB $11.49
- GNLX N/A
- P/E Ratio
- FNWB N/A
- GNLX N/A
- Revenue Growth
- FNWB N/A
- GNLX N/A
- 52 Week Low
- FNWB $8.91
- GNLX $1.60
- 52 Week High
- FNWB $16.12
- GNLX $16.60
- Technical
- Relative Strength Index (RSI)
- FNWB 61.90
- GNLX 41.85
- Support Level
- FNWB $10.50
- GNLX $2.33
- Resistance Level
- FNWB $10.99
- GNLX $3.07
- Average True Range (ATR)
- FNWB 0.30
- GNLX 0.28
- MACD
- FNWB 0.09
- GNLX -0.08
- Stochastic Oscillator
- FNWB 100.00
- GNLX 13.40
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.